Student Name
Capella University
NURS-FPX4015 Pathophysiology, Pharmacology, and Physical Assessment: A Holistic Approach to Patient-Centered Care
Prof. Name
Date
Comprehensive Head-to-Toe Assessment
This comprehensive head-to-toe assessment provides a holistic view of the patient’s overall health by integrating subjective complaints, objective clinical observations, and general wellness indicators. Beyond the standard physical examination, particular attention is given to blood glucose monitoring, cardiovascular assessment, and foot integrity. These components are especially critical for patients with diabetes, as they allow early detection of complications associated with impaired circulation and peripheral neuropathy. Timely identification of these risks facilitates interventions that promote health, prevent deterioration, and guide individualized care plans tailored to the patient’s long-term health objectives.
Introduction to Assessment
The assessment begins with a structured introduction to foster patient rapport and explain the procedure. Patients are informed that a thorough evaluation from head to toe will be conducted, including both physical examinations and symptom-based questioning. This approach ensures a holistic understanding of the patient’s current health status.
The patient under evaluation is alert, oriented, and communicates effectively. Sleep patterns are reported as adequate, averaging eight hours per night. Home-monitored vital signs indicate a blood pressure of 140/85 mmHg and a heart rate between 78–82 beats per minute. Blood glucose readings range from 130–140 mg/dL, and the most recent hemoglobin A1C is 8.9%, indicating suboptimal glycemic control.
Medical history is significant for hypertension, hyperlipidemia, and recently diagnosed type 2 diabetes mellitus. Current medications include metoprolol (50 mg twice daily), atorvastatin (80 mg daily), and gabapentin for neuropathic symptoms. The patient also reports the use of Tung seed as an herbal supplement.
Family history reveals a strong predisposition to metabolic and cardiovascular disorders, including diabetes, hypertension, and hyperlipidemia. Lifestyle patterns show moderate physical activity, such as weekend walks, alongside dietary habits that include processed foods, potentially contributing to disease progression.
Physical Examination Findings
Eyes and Oral Cavity
Question: What findings were observed in the eyes and oral cavity, and what is their significance?
The patient’s eyes are clear, without redness or jaundice, suggesting no acute ocular infection or liver dysfunction. Vision is currently reported as normal, though ongoing monitoring is necessary due to the risk of diabetic retinopathy. Examination of the oral cavity identifies mild dryness of the lips and tongue, possibly reflecting dehydration or hyperglycemia-related polydipsia. Early recognition of these signs is essential for preventing further complications in diabetic patients.
Neurological and Sensory Assessment
Question: What neurological symptoms are present, and what do they indicate?
The patient reports tingling and burning sensations in both feet, rated 5/10 in intensity. Sensory testing reveals decreased discrimination between sharp and dull stimuli, consistent with peripheral neuropathy. Motor function remains intact, with no weakness or abnormal movements observed. Occasional lightheadedness is noted. These findings indicate nerve damage secondary to chronic hyperglycemia, a common complication in type 2 diabetes that can lead to functional impairment if unaddressed.
Skin, Circulation, and Extremities
Question: What does the assessment of the skin and circulation reveal?
Examination of the lower extremities shows normal skin coloration with mild dryness. No ulcers or open lesions are present. Peripheral pulses, including dorsalis pedis and posterior tibial, are palpable but weak. While the skin is generally warm, slightly cooler toes may suggest early vascular compromise. No edema is observed. These findings indicate potential early peripheral arterial disease and warrant continued monitoring to prevent progression.
Cardiovascular Assessment
Question: What are the key cardiovascular findings?
The patient exhibits a regular heart rhythm with no complaints of chest pain, palpitations, or dyspnea. Blood pressure is elevated at 140/85 mmHg. Auscultation reveals a stenotic murmur at the fourth intercostal space, consistent with previous evaluations and suggestive of arterial narrowing. These observations indicate an increased risk for cardiovascular complications and highlight the importance of ongoing monitoring and management.
Summary of Key Findings
| System | Observation | Clinical Significance |
|---|---|---|
| Eyes | Clear, no redness or jaundice | Stable vision; monitor for diabetic retinopathy |
| Oral Cavity | Dry lips and tongue | Possible dehydration or hyperglycemia |
| Neurological | Tingling, burning, reduced sensation | Indicative of peripheral neuropathy |
| Cardiovascular | Elevated BP, regular HR, murmur | Increased cardiovascular risk |
| Skin | Mild dryness, no wounds | Early warning without active lesions |
| Circulation | Reduced peripheral pulses | Suggests risk of peripheral arterial disease |
Discussion of Diagnosis and Findings
Question: What diagnosis is supported by the assessment findings?
The patient’s clinical presentation is consistent with type 2 diabetes mellitus with peripheral neuropathy (Bodman & Varacallo, 2024). The elevated hemoglobin A1C of 8.9% confirms chronic hyperglycemia, which contributes to nerve and microvascular damage.
Coexisting hypertension and hyperlipidemia further elevate vascular risk. The strong family history of metabolic and cardiovascular disorders amplifies susceptibility, highlighting the need for comprehensive management targeting glucose regulation, vascular protection, and neuropathic symptom control (Bays, 2021).
Understanding of Pharmacological Needs
Question: What are the primary goals of pharmacological management?
Pharmacological interventions aim to regulate blood glucose, alleviate neuropathic symptoms, and reduce cardiovascular risk. Antidiabetic medications control hyperglycemia, gabapentin manages nerve pain, and atorvastatin with metoprolol supports cardiovascular health. Monitoring for side effects—such as gastrointestinal upset, dizziness, or muscle pain—is essential to ensure patient safety.
NURS FPX 4015 Assessment 5 Comprehensive Head-to-Toe Assessment
| Medication | Purpose | Potential Side Effects |
|---|---|---|
| Metformin | Regulate blood glucose | Nausea, gastrointestinal upset |
| Gabapentin | Reduce neuropathic pain | Drowsiness, dizziness |
| Atorvastatin | Lower cholesterol | Muscle discomfort |
| Metoprolol | Control blood pressure | Fatigue, dizziness |
| Tung Seed | Herbal supplement | Possible drug interactions |
Education Plan
Question: What education should be provided to the patient?
Patient education focuses on medication adherence, lifestyle modification, and preventive care. Patients should monitor blood glucose daily, follow a balanced diet, and engage in regular physical activity. Emphasis is placed on foot care, including daily inspections, wearing appropriate footwear, and avoiding injuries to prevent infections (American Diabetes Association, 2024). Education also includes recognizing medication side effects and reporting concerns promptly.
Understanding the Pathophysiology
Question: How does type 2 diabetes lead to complications such as neuropathy?
Type 2 diabetes involves insulin resistance, leading to chronic hyperglycemia (CDC, 2024). Persistent high blood sugar damages small blood vessels and peripheral nerves, especially in the lower extremities, resulting in tingling, burning, and pain. Vascular damage may extend to the eyes and kidneys, contributing to broader systemic complications (Yachmaneni et al., 2023).
Critical Thinking and Clinical Reasoning: Establishing Care Priorities
Question: What are the priority areas in patient care?
Priority care objectives include stabilizing blood glucose, preserving nerve function, improving circulation, and mitigating cardiovascular risk. Early detection, regular monitoring, and preventive strategies align with professional guidelines emphasizing glycemic control, foot assessments, and vascular health management (ADA, 2023).
Conclusion
Optimal management of this patient requires multifaceted care, including pharmacological therapy, lifestyle modification, and continuous monitoring. Adherence to medications and preventive strategies reduces complications, improves symptom control, and enhances quality of life. Patient education and support are essential to foster long-term self-management and confidence in health maintenance.
References
American Diabetes Association (ADA). (2023). American diabetes association releases 2023 standards of care in diabetes to guide prevention, diagnosis, and treatment for people living with diabetes. https://diabetes.org/newsroom/american-diabetes-association-2023-standards-care-diabetes-guide-for-prevention-diagnosis-treatment-people-living-with-diabetes
American Diabetes Association. (2024). Standards of care in diabetes.Bays, H. (2021). Ten things to know about ten cardiovascular disease risk factors. American Journal of Preventive Cardiology, 5(100149), 100149. https://doi.org/10.1016/j.ajpc.2021.100149
NURS FPX 4015 Assessment 5 Comprehensive Head-to-Toe Assessment
Bodman, M. A., & Varacallo, M. (2024). Diabetic neuropathy. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK442009/
Centers for Disease Control and Prevention (CDC). (2024). About insulin resistance and type 2 diabetes. https://www.cdc.gov/diabetes/about/insulin-resistance-type-2-diabetes.html
Cleveland Clinic. (2025). Side effects of metformin: Watch out for these signs. https://health.clevelandclinic.org/side-effects-of-metformin
NURS FPX 4015 Assessment 5 Comprehensive Head-to-Toe Assessment
Mayo Clinic. (2024). Atorvastatin (oral route) description and brand names. https://www.mayoclinic.org/drugs-supplements/atorvastatin-oral-route/description/drg-20067003
Yachmaneni, A., Jajoo, S., Mahakalkar, C., Kshirsagar, S., & Dhole, S. (2023). A comprehensive review of the vascular consequences of diabetes in the lower extremities. Cureus, 15(10). https://doi.org/10.7759/cureus.47525
Yang, Y., Zhao, B., Wang, Y., Lan, H., Liu, X., Hu, Y., & Cao, P. (2025). Diabetic neuropathy: Cutting-edge research and future directions. Signal Transduction and Targeted Therapy, 10(1). https://doi.org/10.1038/s41392-025-02175-1